Harrow Health Remains Confident In Its 2023 Financial Guidance Of $135M-$143M (Est. $140.76M) In Net Revenues And $44M-$50M In Adjusted EBITDA
Portfolio Pulse from Benzinga Newsdesk
Harrow Health has reaffirmed its 2023 financial guidance, expecting net revenues of $135M-$143M and adjusted EBITDA of $44M-$50M. The estimated net revenue is $140.76M.
August 09, 2023 | 9:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Harrow Health's reaffirmation of its 2023 financial guidance could instill confidence in investors, potentially leading to a positive impact on its stock price.
Harrow Health's reaffirmation of its 2023 financial guidance indicates the company's confidence in its future performance. This could be seen as a positive signal by investors, potentially leading to increased demand for the company's stock and a subsequent rise in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100